Registered South Africa · SAHPRA

LYMECYCLINE ACTIVO

Lymecycline

57/20.1.1/0408 antiinfectives for systemic use INN generic

What it does

Lymecycline is an antibiotic that helps treat various bacterial infections.

Commonly used for: acne, skin infections, respiratory infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
57/20.1.1/0408
Registration date
2025/06/24
Expiry date
-
Status
Registered
Active ingredient
Lymecycline
Dosage form
-
Strength
-
Pack size
-
Therapeutic class
-
ATC class (WHO)
J01AA - Tetracyclines
RxNorm RxCUI
6513
Manufacturer / MAH
-
Applicant / LTR
Activo Health (Pty) Ltd
Country of origin
-

Source: South African Health Products Regulatory Authority · fetched 2026-04-15 21:29:46 · updated 2026-09-20 04:02:14

Drug Interactions

8
Check interactions

Pharmacodynamic Warnings

Lymecycline appears in TABLE 1: Drugs that cause hepatotoxicity

Severe (1)

Tetracyclines - decreases absorption

Strontium is predicted to decrease the absorption of tetracyclines. Avoid. Theoretical Sucralfate

Severe Theoretical

Moderate (3)

Lithium - increases risk of lithium toxicity

Tetracyclines are predicted to increase the risk of lithium toxicity when given with lithium. Avoid or adjust dose.

Moderate Anecdotal

Tetracyclines - decreases concentration

Fosphenytoin is predicted to decrease the concentration of tetracyclines (doxycycline). Adjust dose.

Moderate Theoretical

Tetracyclines - decreases exposure

Rifampicin modestly decreases the exposure to tetracyclines (doxycycline). Adjust dose.

Moderate Study

Unknown (4)

Tetracyclines - decreases exposure

Mitotane is predicted to decrease the exposure to tetracyclines (eravacycline). Adjust eravacycline dose, p. 625.

Unknown Study

Tetracyclines - decreases exposure

Rifampicin is predicted to decrease the exposure to tetracyclines (eravacycline). Adjust eravacycline dose, p. 625.

Unknown Study

Tetracyclines - decreases exposure

St John's wort is predicted to decrease the exposure to tetracyclines (eravacycline). Adjust eravacycline dose, p. 625.

Unknown Theoretical

Tetracyclines - decreases absorption

Oralzincispredictedtodecreasetheabsorptionof tetracyclines.Separateadministrationby2to3hours. oTheoretical https://www.facebook.c (Books-Courses-Medic

Unknown Theoretical

Data from BNF 85 (British National Formulary). This is not a substitute for professional medical advice. Matched via: class

Disclaimer: This information is sourced from South African Health Products Regulatory Authority (South Africa). Always consult a qualified healthcare professional before using any medication.

About this medicine

Lymecycline is an antibiotic that helps treat various bacterial infections.

What it treats

  • acne
  • skin infections
  • respiratory infections

How it works

It works by stopping the growth of bacteria that cause infections.

Who it's for

It is for people with bacterial infections, including teenagers and adults with acne.

Drug class

Tetracyclines

Cautions

  • • Avoid using with other drugs that can harm the liver.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: Lymecycline

BNF-referenced

Lymecycline is a member of the tetracycline class of antibiotics, which are effective against a broad range of bacterial infections. It works by inhibiting bacterial protein synthesis, making it useful in treating various infections, including those caused by chlamydia, rickettsia, and mycoplasma. It is commonly used in the management of acne vulgaris as an adjunct to topical treatments.

Indications

  • Bacterial infections
  • Acne vulgaris (adjunct to topical treatment)
  • Chlamydia infections
  • Rickettsial infections
  • Mycoplasma infections

Dosage

Children: For children aged 12–17 years, the recommended dosage is 408 mg once daily. For specific pediatric dosing, refer to the BNF for Children.

Adults: For adults, the typical dosage of Lymecycline is 408 mg once daily, which can be increased to 1.224–1.632 g daily in severe infections.

Mechanism of action

Lymecycline exerts its antibacterial effect by binding to the 30S ribosomal subunit of bacteria, inhibiting the attachment of aminoacyl-tRNA to the mRNA-ribosome complex. This action prevents protein synthesis, which is essential for bacterial growth and reproduction.

Pharmacodynamics

Lymecycline has a broad spectrum of activity against gram-positive and gram-negative bacteria. It is particularly effective against susceptible strains of bacteria responsible for respiratory tract infections, urinary tract infections, and certain sexually transmitted infections. Its efficacy is partly due to its ability to penetrate bacterial cells and accumulate at the site of action.

Pharmacokinetics

Lymecycline is absorbed well from the gastrointestinal tract, with peak plasma concentrations typically occurring 1-2 hours after oral administration. It has a bioavailability of approximately 60-70%. The drug is primarily excreted in the urine, both as unchanged drug and metabolites, with a half-life of about 8-12 hours. Adjustments may be necessary in cases of renal impairment.

Contra-indications

  • Hypersensitivity to lymecycline or other tetracyclines
  • Severe renal impairment
  • Pregnancy (especially during the first trimester)

Adverse effects

  • Gastrointestinal discomfort
  • Photosensitivity
  • Visual impairment
  • Skin hyperpigmentation (with long-term use)
  • Severe cutaneous adverse reactions (SCARs)
  • Tinnitus

Interactions

  • Antacids containing aluminum, calcium, or magnesium may reduce absorption
  • Iron supplements may also decrease the absorption of lymecycline
  • Concurrent use with other nephrotoxic drugs should be approached with caution

Precautions

  • Caution in patients with renal impairment
  • Monitor for signs of fungal infections, particularly in those predisposed to oral candidiasis
  • Avoid excessive sun exposure due to risk of photosensitivity

Pregnancy

Lymecycline is contraindicated during pregnancy, particularly in the first trimester; however, it may be considered if the entire treatment course can be completed before 15 weeks' gestation in unavoidable malaria prophylaxis.

Breast-feeding

Lymecycline should be used with caution during breastfeeding as it may be excreted in breast milk.

Storage

Store in a refrigerator (2–8°C) and protect from light.

Formulations

  • Lymecycline 408 mg capsules
BNF 85 (British National Formulary) p.645 BNF for Children 2019-2020 p.388 PubChem / pathway

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: Lymecycline

PubChem CID 54707177

Molecular formula: C29H38N4O10

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.